Conformis Suspends All Distribution Operations and Business Development in Russia
BILLERICA, Mass., March 02, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), announced that it was suspending all distribution operations to...
News
Owkin welcomes leading immuno-oncology professor as Chief Medical Officer and senior pharma exec as SVP Data Science
Featured Image for Owkin Featured Image for OwkinNEW YORK, March 02, 2022 (GLOBE NEWSWIRE) -- Owkin appointed Professor Vassili Soumelis...
Oculis Strengthens Leading Ophthalmology Pipeline by In-Licensing Neuroprotective Drug Candidate for Glaucoma from Accure Therapeutics
Oculis Strengthens Leading Ophthalmology Pipeline by In-Licensing Neuroprotective Drug Candidate for Glaucoma from Accure Therapeutics First-in-class peptidomimetic with distinct MoA...
LEXEO Therapeutics Announces Positive Initial Data from Ongoing Phase 1/2 Clinical Trial of AAV-based Gene Therapy Candidate LX1001 in Patients with Alzheimer’s Disease
– In the initial clinical data from low-dose cohort of the ongoing trial, we observed that LX1001 expressed the protective...
Cytokinetics Announces Cohort 4 of REDWOOD-HCM Is Open to Enrollment
Cohort 4 to Enroll Patients with Non-Obstructive Hypertrophic CardiomyopathySOUTH SAN FRANCISCO, Calif., March 02, 2022 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated...
Harpoon Therapeutics Receives FDA Fast Track Designation for HPN217
SOUTH SAN FRANCISCO, Calif., March 02, 2022 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing...
Statera Biopharma Submits Phase 1 Clinical Trial Protocol to FDA for Investigational Treatment of Long-Haul COVID-19
Statera developing STAT-205 as novel therapy for immune modulation in treating post-acute (long-haul) patients with SARS-CoV-2 (COVID-19)FORT COLLINS, Colo., March...
SIGA Announces Start of TPOXX® Post-Exposure Prophylactic (“PEP”) Clinical Trials
NEW YORK, March 02, 2022 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on...
Generation Bio to Participate in 42nd Annual Cowen Health Care Conference
CAMBRIDGE, Mass., March 02, 2022 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for...
Avalo Therapeutics Reports 2021 Financial Results and Provides Business Updates
Dr. Garry Neil and Chris Sullivan promoted to Chief Executive Officer and Chief Financial Officer, respectivelyAnnounced plans to initiate a...
Surface Oncology Reports Financial Results and Corporate Highlights for Fourth Quarter and Full Year 2021
Continued progress advancing next-generation antibody portfolio, with ongoing clinical trials evaluating the broad potential of SRF388 and SRF617 across multiple...
Plantable Health’s Clinical Trials Aim to Revolutionize U.S. Healthcare
New York, New York--(Newsfile Corp. - March 2, 2022) - Plantable Health Inc. (NEO: PLBL) ("Plantable" or the "Company") today...
Bloom Health Partners Completes Fiscal Q1 2022 with $5.8M in Revenue and Maintains Guidance for Full Fiscal Year
Vancouver, British Columbia--(Newsfile Corp. - March 2, 2022) - Bloom Health Partners Inc. (CSE: BLMH) (OTCQB: BLMHF) (FSE: D840) ("Bloom"...
Inkblot Therapy Launches Its New iCBT Solution Tranquility by Inkblot
Toronto, Ontario--(Newsfile Corp. - March 2, 2022) - Inkblot Therapy is pleased to announce its new internet-based cognitive behavioural therapy...
Lumen Launches First Metabolic Food Tracker Revealing Impact on Metabolism in Real Time
NEW YORK--(BUSINESS WIRE)--#lumenmetabolism--Lumen , a health technology company at the forefront of metabolic health, today launched a pioneering food logging...
86% of Patients Say Wearable Devices Improve Health Outcomes, According to Software Advice Research
Study of patients prescribed wearables found that the majority experienced improved health, quality of life, and quality of care AUSTIN,...
Caduceus Capital Partners Invests in UptimeHealth
NASHVILLE, Tenn.--(BUSINESS WIRE)--#digitalhealth--Caduceus Capital Partners has finalized its investment in UptimeHealth, a health technology company that simplifies medical device service...
QGenda Introduces ProviderCloud™, the Scheduling-Centric Provider Operations Platform for Healthcare
ProviderCloudTM brings together disparate provider systems to centralize provider operations information so healthcare organizations can effectively manage their entire workforce...
Establishment Labs to Present at the Cowen 42nd Annual Health Care Conference
SANTA BARBARA, Calif.--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and...
Evotec Presents Strategic Roadmap Towards Precision Medicine and Confirms Goals of Action Plan 2025 at Capital Markets Day
LAUNCH OF E.MPD, THE LEADING GLOBAL MOLECULAR PATIENT DATABASEROLL-OUT AND ACCELERATION OF AI/ML PRECISION TECHNOLOGIES TO INCREASE PROBABILITY OF SUCCESS...